Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals

European Journal of Clinical Pharmacology

Volumn 60, Issue 7, 2004, Pages 467-471

  Bakayev, Valery V ^a   Mohammadi, Forozan ^a   Bahadori, Moslem ^a   Sheikholslami, Mariam ^a   Javeri, Arash ^a   Masjedi, Mohammad R ^a   Velayati, Ali A ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acetylation; NAT2; Polymorphism

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE;

ACCURACY; ACETYLATION; ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; NAT2 GENE; NUCLEIC ACID ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

ACETYLATION; ADULT; AGED; ALLELES; ARYLAMINE N-ACETYLTRANSFERASE; FEMALE; GENOTYPE; HUMANS; IRAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 5344266737     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-004-0799-z     Document Type: Article

References (28)

1. Adams CH, Werely CJ, Victor TC, Hoal EG, Rossouw G, van Helden PD (2003) Allele frequencies for glutathione S-transferase and N-acetyltransferase 2 differ in African population groups and may be associated with oesophageal cancer or tuberculosis incidence. Clin Chem Lab Med 41:600-605
2. Anitha A, Banerjee M (2003) Arylamine N-acetyltransferase 2 polymorphism in the ethnic populations of South India. Int J Mol Med 11:125-131
3. Blum M, Demierre A, Grant DM, Heim M, Meyer UA (1991) Molecular mechanism of slow acetylation of drugs and carcinogens in human. Proc Natl Acad Sci U S A 88:5237-5241
4. Blum M, Grant DM, McBride W, Heim M, Meyer UA (1990) Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol 9:193-203
5. Bönicke R, Reif W (1953) Enzymatic inactivation of isonicotinic acid hydrazide in humans and animals. Arch Exp Pathol Pharmacol 220:321-333
6. Cascorbi I, Drakoulis N, Brockmöller J, Maurer A, Sperling K, Roots I (1995) Arylamine N-acetyltransferase mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Am J Hum Genet 57:581-592
7. Deguchi T, Mashimo M, Suzuki T (1990) Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. J Biol Chem 265:12757-12760
8. Evans DAP (1989) N-acetyltransferase. Pharmacol Ther 42:157-234
9. Gawronska-Szklarz B, Pawlik A, Czaja-Bulsa G, Gornik W, Luszawska-Kutrzeba T, Wrzesniewska J (2001) Genotype of N-acetyltransferase 2 (NAT2) polymorphism in children with immunoglobulin E-mediated food allergy. Clin Pharmacol Ther 69:372-378
10. Gertig DM, Hankinson SE, Hough H, Spiegelman D, Colditz GA, Willett WC, Kelsey KT, Hunter DJ (1999) N-acetyltransferase 2 genotypes, meat intake and breast cancer risk. Int J Cancer 80:13-17
11. Graf T, Broly F, Hoffmann F, Probst M, Meyer UA, Howald H (1992) Prediction of phenotype for acetylation and for debrisoquine hydroxylation by DNA-tests in healthy human volunteers. Eur J Clin Pharmacol 43:399-403
12. Hamasaki T, Inatomi H, Katoh T, Aono H, Ikuyama T, Muratani T, Matsumoto T (2003) N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men. Int J Urol 10:167-173
13. Hamdy SI, Hiratsuka M, Narahara K, Endo N. El-Enany M, Moursi N, Ahmed MS-E, Mizugaki M (2003) Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br J Clin Pharm 55:560-569
14. Hayes RB, Bi W, Rothman N, Caporaso N, Broly F, Feng P, You X, Yin S, Woosley RL, Meyer UA (1993) N-acetylation phenotype and genotype and risk of bladder cancer, in benzidine-exposed workers. Carcinogenesis 14:675-678
15. Huang YS, Chern HD, Su WJ, Wu JC, Lai SL, Yang SY (2002) Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Hepatol 35:883-889
16. Lee WEJD, Zhao B, Seow-Choen F (1998) Relationship between polymorphism of N-acetyltransferase gene and susceptibility to colorectal carcinoma in a Chinese population. Pharmacogenetics 8:513-517
17. Left MA, Fretland AJ, Doll MA, Hein DW (1999) Novel human N-acetyltransferase 2 alleles that differ in mechanism for slow acetylator phenotype. J Biol Chem 274:34519-34522
18. Lin HJ, Han CY, Lin BK, Hardy S (1994) Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics 4:125-134
19. Mashimo M, Suzuki T, Abe M, Deguchi T (1992) Molecular genotyping of N-acetylation polymorphism to predict phenotype. Hum Genet 90:139-143
20. Meyer UA, Zanger UM, Grant D, Blum M (1990) Genetic polymorphisms of drug metabolism. In: Testa B (ed) Advances of drug research, vol 19. Academic, London, pp 197-241
21. Mitchell JR, Zimmerman HJ, Ishak KG, Thorgeirsson UP, Timbrell JA, Snodgrass WR, Nelson SD (1976) Isoniazid liver injury: clinical spectrum, pathology and probable pathogenesis. Ann Intern Med 84:181-192
22. Rothman N, Hayes RB, Bi W, Caporaso N, Broly F, Woosley RL, Yin S, Feng P, You X, Meyer UA (1993) Correlation between N-acetyltransferase activity and NAT2 genotype in Chinese males. Pharmacogenetics 3:250-255
23. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, New York
24. Sardas S, Lahijany B, Cok I, Karakaya AE (1993) N-acetylation phenotyping with sulfamethazine in an Iranian population. Pharmacogenetics 3:131-134
25. Vatsis KP, Weber WW, Bell DA, Dupret J-M, Price-Evans DA, Grant DM, Hein DW, Lin HJ, Meyer UA, Relling MV, Sim E, Suzuki T, Yamazoe Y (1995) Nomenclature for N-acetyltransferases. Pharmacogenetics 5:1-17
26. Weber WW, Cohen SN (1968) The mechanism of isoniazid acetylation by human N-acetyltransferase. Biochim Biophys Acta 151:276-278
27. Woolhouse NM, Qureshi MM, Bastaki SM, Patel M, Abdulrazzaq Y, Bayoumi RA (1997) Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis. Pharmacogenetics 7:73-82
28. http://anthro.unige.ch/arlequin